Ischemic Stroke: Histological Thrombus Composition and Pre-Interventional CT Attenuation Are Associated with Intervention Time and Rate of Secondary Embolism

Cerebrovasc Dis. 2017;44(5-6):344-350. doi: 10.1159/000481578. Epub 2017 Oct 31.

Abstract

Background and purpose: The introduction of stent retrievers has made the complete extraction and histological analysis of human thrombi possible. A number of large randomized trials have proven the efficacy of thrombectomy for ischemic stroke; however, thrombus composition could have an impact on the efficacy and risk of the intervention. We therefore investigated the impact of histologic thrombus features on interventional outcome and procedure-related embolisms. For a pre-interventional estimation of histologic features and outcome parameters, we assessed the pre-interventional CT attenuation of the thrombi.

Methods: We prospectively included all consecutive patients with occlusion of the middle cerebral artery who underwent thrombectomy between December 2013 and February 2016 at our university medical center. Samples were histologically analyzed (H&E, Elastica van Gieson, Prussian blue); additionally, immunohistochemistry for CD3, CD20, and CD68/KiM1P was performed. Main thrombus components (fibrin, erythrocytes, and white blood cells) were determined and compared to intervention time, frequency of secondary embolisms, as well as additional clinical and interventional parameters. Additionally, we assessed the pre-interventional CT attenuation of the thrombi in relation to the unaffected side (rHU) and their association with histologic features.

Results: One hundred eighty patients were included; of these, in 168 patients (93.4%), complete recanalization was achieved and 27 patients (15%) showed secondary embolism in the control angiogram. We observed a significant association of high amounts of fibrin (p < 0.001), low percentage of red blood cells (p < 0.001), and lower rHU (p < 0.001) with secondary embolism. Higher rHU values were significantly associated with higher amounts of fibrin (p ≤ 0.001) and low percentage of red blood cells (p ≤ 0.001). Additionally, high amounts of fibrin were associated with longer intervention times (p ≤ 0.001), whereas thrombi with high amounts of erythrocytes correlated with shorter intervention times (p ≤ 0.001). ROC analysis revealed reliable prediction of secondary embolisms for low rHU (AUC = 0.746; p ≤ 0.0001), low amounts of RBC (AUC = 0.764; p ≤ 0.0001), and high amounts of fibrin (AUC = 0.773; p ≤ 0.0001).

Conclusions: Fibrin-rich thrombi with low erythrocyte percentage are significantly associated with longer intervention times. Embolisms in the thrombectomy process occur more often in thrombi with a small fraction of red blood cells and a low CT-density, suggesting a higher fragility of these thrombi.

Keywords: Embolism; Histopathology; Thrombectomy; Thrombus; Thrombus composition.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers / analysis
  • Biopsy
  • Cerebral Angiography / methods*
  • Cerebral Arteries / chemistry
  • Cerebral Arteries / diagnostic imaging*
  • Cerebral Arteries / pathology
  • Cerebral Arteries / surgery*
  • Computed Tomography Angiography / methods*
  • Endovascular Procedures / adverse effects*
  • Endovascular Procedures / methods
  • Female
  • Germany
  • Humans
  • Infarction, Middle Cerebral Artery / drug therapy*
  • Infarction, Middle Cerebral Artery / metabolism
  • Infarction, Middle Cerebral Artery / pathology
  • Infarction, Middle Cerebral Artery / surgery
  • Intracranial Embolism / diagnostic imaging
  • Intracranial Embolism / etiology*
  • Intracranial Thrombosis / diagnostic imaging*
  • Intracranial Thrombosis / metabolism
  • Intracranial Thrombosis / pathology
  • Intracranial Thrombosis / surgery
  • Male
  • Middle Aged
  • Operative Time
  • Patient Safety
  • Predictive Value of Tests
  • Retrospective Studies
  • Risk Factors
  • Thrombectomy / adverse effects*
  • Thrombectomy / methods
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers